Barriers to antiretroviral therapy adherence in rural Mozambique

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Groh, Kate ^a   Audet, Carolyn M ^a,b   Baptista, Alberto ^b   Sidat, Mohsin ^c,d   Vergara, Alfredo ^a,b   Vermund, Sten H ^b,d,e   Moon, Troy D ^b,d,e  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Village at Vanderbilt ^*  (United States)

^c MINISTRY OF HEALTH   (Mozambique)

^d EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^e Friends in Global Health   (Mozambique)

Author keywords

adherence; AIDS; antiretroviral therapy; attitudes; behaviors; compliance; focus groups; health care workers; HIV; Mozambique; rural

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; COMMUNITY CARE; CONFIDENTIALITY; ECONOMICS; FEMALE; HEALTH AUXILIARY; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; INFORMATION PROCESSING; MALE; MOZAMBIQUE; PARTICIPATORY RESEARCH; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; RURAL HEALTH CARE; SOCIOECONOMICS; STATISTICS;

ADULT; ANTI-RETROVIRAL AGENTS; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; COMMUNITY HEALTH SERVICES; COMMUNITY HEALTH WORKERS; COMMUNITY-BASED PARTICIPATORY RESEARCH; CONFIDENTIALITY; FEMALE; FOCUS GROUPS; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MOZAMBIQUE; PROFESSIONAL-PATIENT RELATIONS; QUALITATIVE RESEARCH; RURAL HEALTH SERVICES; SOCIOECONOMIC FACTORS;

EID: 80051625198     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-650     Document Type: Article

References (55)

1. Mozambique: The challenge of HIV/AIDS treatment and care. Commission on HIV/AIDS and Governance in Africa, Maputo: Economic Commission for Africa 2004
2. Report on the global HIV/AIDS epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008 Retrieved January 2, 2011, from, http://data.unaids. org/pub/Report/2008/mozambique-2008-country-progress-report-en.pdf
3. Multi-Sectoral Technical Group for the Fight Against HIV/AIDS in Mozambique: Report on the Revision of the Data for HIV Epidemological Surveillance:Round 2007. Mozambique Ministry of Health, Maputo 2008 Retrieved January 15, 2011, from, http://www.misau.gov.mz/pt/content/download/4637/28101/. /Ronda2007EN.pdf
4. United Nations General Assembly Special Session on HIV and AIDS, Progress Report 2008-9009: Mozambique. UNGASS, Maputo 2010 Retrieved March 14, 2011, from, http://data.unaids.org/pub/Report/2010/mozambique-2010-country-progress- report-en.pdf
5. Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. Koenig SP, Leandre F, Farmer PE, AIDS 2004 18 Suppl 3 21 25 15322480
6. Lessons learned while implementing an HIV/AIDS care and treatment program in rural Mozambique. Moon T, Burlison J, Sidat M, Pires P, Silva W, Solis M, Rocha M, Arregui C, Manders E, Vergara A, Vermund S, Retrovirology: Research and Treatment 2010 1 14
7. World Health Organization, The World Health Report 2006: working together for health Geneva: World Health Organization, WHO Press 2006
8. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation. Pearson CR, Micek M, Simoni JM, Matediana E, Martin DP, Gloyd S, J Acquir Immune Defic Syndr 2006 43 Suppl 1 134 141 17133197
9. Sociocultural and Epidemiological aspects of HIV/AIDS in Mozambique. Audet CM, Burlison JR, Moon TD, Mohsin S, Vergara AE, Vermund SH, BMC International Health and Human Rights 2010
10. Improving adherence to highly active anti-retroviral therapy in Africa: the DREAM programme in Mozambique. Marazzi MC, Bartolo M, Emberti Gialloreti L, Germano P, Guidotti G, Liotta G, Magnano San Lio M, Mancinelli S, Modolo MA, Narciso P, Perno CF, Scarcella P, Tintisona G, Palombi L, Health Educ Res 2006 21 34 42 15947022 (Pubitemid 43244080)
11. [DREAM project early results (drug resources enhancement against AIDS in Mozambique)]. Marazzi MC, Palombi L, Emberti Gialloreti L, Guidotti G, Liotta G, Perno F, Vella S, Narciso P, Ig Sanita Pubbl 2002 58 431 440 12874623
12. Program DREAM (Drug Resource Enhancement against AIDS in Mozambique). World Health Organization, Community of Sant' Egidio, Assist Inferm Ric 2003 22 121 126 13677167
13. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A, AIDS 2001 15 1181 1183 10.1097/00002030-200106150-00015 11416722 (Pubitemid 32549871)
14. Adherence to HIV combination therapy. Chesney MA, Morin M, Sherr L, Soc Sci Med 2000 50 1599 1605 10.1016/S0277-9536(99)00468-2 10795966 (Pubitemid 30129133)
15. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, Montaner JS, AIDS 2002 16 1051 1058 10.1097/00002030-200205030-00012 11953472 (Pubitemid 34499429)
16. Spending more to save more: interventions to promote adherence. Bangsberg DR, Deeks SG, Ann Intern Med 152 54 56 W-13
17. Adherence in antiretroviral therapy: a review of qualitative studies. Vervoort SC, Borleffs JC, Hoepelman AI, Grypdonck MH, AIDS 2007 21 271 281 10.1097/QAD.0b013e328011cb20 17255734 (Pubitemid 46175040)
18. Factors affecting adherence to antiretroviral therapy. Chesney MA, Clin Infect Dis 2000 30 Suppl 2 171 176 10860902
19. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR, JAMA 2006 296 679 690 10.1001/jama.296.6.679 16896111 (Pubitemid 44200639)
20. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL, AIDS 2005 19 1243 1249 10.1097/01.aids.0000180094.04652.3b 16052078 (Pubitemid 41224892)
21. Adherence as therapeutic citizenship: impact of the history of access to antiretroviral drugs on adherence to treatment. Nguyen VK, Ako CY, Niamba P, Sylla A, Tiendrebeogo I, AIDS 2007 21 Suppl 5 31 35 10.1097/01.aids.0000298100. 48990.58 18032936 (Pubitemid 350294904)
22. Explaining adherence success in sub-Saharan Africa: an ethnographic study. Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, Chalamilla G, Bangsberg DR, PLoS Med 2009 6 11 10.1371/journal.pmed.1000011 19175285
23. Socio-economic and health characteristics of HIV-infected patients seeking care in relation to access to the Drug Access Initiative and to antiretroviral treatment in Cote d'Ivoire. Msellati P, Juillet-Amari A, Prudhomme J, Akribi HA, Coulibaly-Traore D, Souville M, Moatti JP, AIDS 2003 17 Suppl 3 63 68 14565611
24. Adherence to antiretroviral therapy: merging the clinical and social course of AIDS. Castro A, PLoS Med 2005 2 338 10.1371/journal.pmed.0020338 16187735 (Pubitemid 43020976)
25. "All I Eat Is ARV'S: The Paradox of AIDS Treatment Interventions in Central Mozambique. Kalofonos IA, Medical Anthropology Quarterly 2010 24 363 380 10.1111/j.1548-1387.2010.01109.x 20949841
26. Interventions to reduce HIV/AIDS stigma: what have we learned? Brown L, Macintyre K, Trujillo L, AIDS Educ Prev 2003 15 49 69 10.1521/aeap.15.1.49.23844 12627743 (Pubitemid 36237152)
27. Stigma and the Ethnographic Study of HIV: Problems and Prospects. Herdt G, AIDS and Behavior 2000 5 141 149 (Pubitemid 35364546)
28. Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: a follow-up study to understand attrition from the antiretroviral program. Roura M, Busza J, Wringe A, Mbata D, Urassa M, Zaba B, AIDS Patient Care STDS 2009 23 203 210 10.1089/apc.2008.0129 19866538
29. Stigma, discrimination and the implications for people living with HIV/AIDS in South Africa. Skinner D, Mfecane S, SAHARA J 2004 1 157 164 17601003
30. Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort study. Heimburger DC, Koethe JR, Nyirenda C, Bosire C, Chiasera JM, Blevins M, Munoz AJ, Shepherd BE, Potter D, Zulu I, Chisembele-Taylor A, Chi BH, Stringer JSA, Kabagambe EK, PLoS One 2010 5 10687 10.1371/journal.pone.0010687 20502700
31. Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence. Mukherjee JS, Ivers L, Leandre F, Farmer P, Behforouz H, J Acquir Immune Defic Syndr 2006 43 Suppl 1 123 126 17133195
32. Information and Comments on Food and Nutritional Security in Mozambique. SETSAN Technical Secretariat for Food Security and Nutrition, Publication n°7, Mpauto 2006 Retrieved April 22, 2011 from, http://www.sadc.int/fanr/ aims/rvaa/Documents/Mozambique/ 2006%20Mozambique%20InfoFlash%20%20Maio%202006%20English%201.pdf
33. Multiple Indicators Cluster Survey, 2008. National Statistics Institute, Maputo 2009 Retrieved on July 17, 2001 from http://www.childinfo.org/files/ MICS3-Mozambique-FinalReport-2008.pdf
34. Professionalism, patient satisfaction and quality of health care: Experience during Zimbabwe's structural adjustment programme. Bassett MT, Bijlmakers L, Sanders DM, Social Science & Medicine 1997 45 1845 1852 10.1016/S0277-9536(97)00122-6 21853540 (Pubitemid 27525985)
35. Barriers to adherence to antiretroviral treatment: the perspectives of patient advocates. Kagee A, Delport T, J Health Psychol 2010 15 1001 1011 10.1177/1359105310378180 20801946
36. Culture and clinical care. Folk illness beliefs and behaviors and their implications for health care delivery. Pachter LM, JAMA 1994 271 690 694 10.1001/jama.271.9.690 8309032 (Pubitemid 24061704)
37. Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication? Ashton CM, Haidet P, Paterniti DA, Collins TC, Gordon HS, O'Malley K, Petersen LA, Sharf BF, Suarez-Almazor ME, Wray NP, Street RL Jr, J Gen Intern Med 2003 18 146 152 10.1046/j.1525-1497.2003.20532.x 12542590 (Pubitemid 36278952)
38. Doctor-Patient Communication, Cultural Competence, and Minority Health: Theoretical and Empirical Perspectives. Perloff RM, Bonder B, Ray GB, Ray EB, Siminoff LA, American Behavioral Scientist 2006 49 835 852 10.1177/ 0002764205283804 (Pubitemid 43170638)
39. Mozambican healers join government in fight against AIDS. Fleming J, J Int Assoc Physicians AIDS Care 1995 1 32 11362966
40. Green EC, AIDS and STDs in Africa: Bridging the Gap between Traditional Healing and Modern Medicine Boulder, CO: Westview Press 1994
41. The participation of African traditional healers in AIDS/STD prevention programmes. Green EC, AIDSLink 1995 36 14 15
42. Traditional healers and AIDS in Uganda. Green EC, J Altern Complement Med 2000 6 1 2 10.1089/acm.2000.6.1 10706229 (Pubitemid 30112047)
43. The experience of an AIDS prevention program focused on South African traditional healers. Green EC, Zokwe B, Dupree JD, Soc Sci Med 1995 40 503 515 10.1016/0277-9536(94)E0105-2 7725124
44. Defining minimum standards of practice for incorporating African traditional medicine into HIV/AIDS prevention, care, and support: a regional initiative in eastern and southern Africa. Homsy J, King R, Tenywa J, Kyeyune P, Opio A, Balaba D, J Altern Complement Med 2004 10 905 910 15650481 (Pubitemid 39507047)
45. Traditional healers in South Africa: a parallel health care system. Kale R, BMJ 1995 310 1182 1185 7767156
46. South Africa's health. Traditional healers may cause dangerous delays. Smyth A, Martin M, Cairns J, BMJ 1995 311 948 7580572
47. Mozambique Enlists Healers in AIDS Prevention. Swarns RL, The New York Times Company. New York 1999 Retrieved on January 13, 2011 from http://www.nytimes.com/1999/12/06/world/mozambique-enlists-healers-in-aids- prevention.html
48. Traditional Healers in Zambézia Province, Mozambique: HIV Prevention, Knowledge, and Treatment Practices. Audet CM, Blevins M, Sidat M, Moon TD, Pires P, Vergara AE, Vermund SH, In XVIII Interational AIDS Conference; July 18-23, 2010; Vienna, Austria. TUPE0606
49. Delay between first HIV-related symptoms and diagnosis of HIV infection in patients attending the internal medicine department of the Fondation Jeanne Ebori (FJE), Libreville, Gabon. Okome-Nkoumou M, Okome-Miame F, Kendjo E, Obiang GP, Kouna P, Essola-Biba O, Bruno Boguikouma J, Mboussou M, Clevenbergh P, HIV Clin Trials 2005 6 38 42 10.1310/ULR3-VN8N-KKB5-05UV 15765309 (Pubitemid 40533112)
50. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. Dahab M, Charalambous S, Hamilton R, Fielding K, Kielmann K, Churchyard GJ, Grant AD, BMC Public Health 2008 8 63 10.1186/1471-2458-8-63 18282286 (Pubitemid 351467620)
51. (ARV-) Free State? The moratorium's threat to patients' adherence and the development of drug-resistant HIV. El-Khatib Z, Richter M, S Afr Med J 2009 99 412 414 19739316
52. Missing the Target #5: Improving AIDS Drug Access and Advancing Health Care for All. International Treatment Preparedness Coalition, 2007 Retrieved on Decepmber 20, 2010 from, http://www.soros.org/initiatives/health/focus/access/ articles-publications/publications/missing-20071201/missing-20071201.pdf
53. Veenstra N, Whiteside A, Gibbs A, Lalloo D, Unplanned ART treatment interruptions in southern Africa: what can we do to minimise the long-term risks? KwaZulu-Natal, South Africa: Health Economics and HIV/AIDS Research Division (HEARD) 2010
54. Bridging the gap between antiretroviral access and adherence in Mexico. Campero L, Herrera C, Kendall T, Caballero M, Qual Health Res 2007 17 599 611 10.1177/1049732307301335 17478643 (Pubitemid 46681159)
55. Use of traditional medicine among pregnant women in Lusaka, Zambia. Banda Y, Chapman V, Goldenberg RL, Stringer JS, Culhane JF, Sinkala M, Vermund SH, Chi BH, J Altern Complement Med 2007 13 123 127 10.1089/acm.2006.6225 17309386